Synaptic plasticity: one STEP at a time

AGY Therapeutics Inc., 270 E. Grand Avenue, South San Francisco, CA 94080, USA.
Trends in Neurosciences (Impact Factor: 12.9). 09/2006; 29(8):452-8. DOI: 10.1016/j.tins.2006.06.007
Source: PubMed

ABSTRACT Striatal enriched tyrosine phosphatase (STEP) has recently been identified as a crucial player in the regulation of synaptic function. It is restricted to neurons within the CNS and acts by downregulating the activity of MAP kinases, the tyrosine kinase Fyn and NMDA receptors. By modulating these substrates, STEP acts on several parallel pathways that impact upon the progression of synaptic plasticity. Here, we review recent advances that demonstrate the importance of STEP in normal cognitive function, and its possible involvement in cognitive disorders such as Alzheimer's disease.

Download full-text


Available from: Paul Lombroso, Oct 07, 2014
  • Source
    • "This finding is in accord with our previous study demonstrating that motor learning induces genes expression [7]. The current proposed molecular model is that STEP activation acts as a tonic brake on synaptic transmission, which is associated with a decline in memory function [37]–[39]. Dephosphorylation of STEP increases its activity that will, in turn, inactivates key signaling molecules reinforcing synaptic plasticity, such as extracellular signal-regulated kinase 1/2 (ERK1/2) or NR2B subunit of N-methyl-D-aspartate receptors (NMDARs) [23], [40], [41]. In accord with this contention, STEP inhibition in CA1 hippocampal neurons enhanced transmission and occluded LTP induction [42]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Recently, striatal-enriched protein tyrosine phosphatase (STEP) and its upstream regulator protein kinase A (PKA) have been suspected to play a role in the intracellular mechanisms of fear conditioning and spatial memory. However, whether they contribute to the learning and memory of motor skills is totally unknown. In this study, we have investigated the role of STEP and PKA activities during motor skill learning associated with the accelerating rotarod task. We observed that learning the rotarod task differentially modulated the levels of phosphorylated STEP61 at serine 221, a site directly regulated by PKA, in the hippocampus, motor cortex and striatum. In a second set of experiments, we have pharmacologically inhibited PKA by the injection of Rp-cAMPS directly into the dorsal striatum of mice before rotarod trainings. PKA phosphorylation of STEP prevents the dephosphorylation of STEP substrates, whereas inhibition of PKA promotes STEP activity. Striatal PKA inhibitions dose-dependently impaired mice performances on the accelerating rotarod task. General motor abilities testing revealed an intact motor control in mice treated with 5 and 20 µg of Rp-cAMPS, but not at the highest dose of 40 µg. This suggested that motor learning was selectively affected by PKA inhibition at lower doses. Most notably, striatal inhibition of PKA reduced the levels of phosphorylated STEP61 at serine 221. Our data support that inactivation of STEP61 by the PKA activity is part of the molecular process associated with motor skill learning.
    PLoS ONE 01/2014; 9(1):e86988. DOI:10.1371/journal.pone.0086988 · 3.23 Impact Factor
  • Source
    • "Thus, A b would ultimately reduce GluN2B phosphorylation at a regulatory tyrosine (1472) site, which is responsible for controlling the traf fi cking of NMDARs to the cell surface (Snyder et al. 2005 ) . The ultimate effect of A b is to decrease surface expression of GluN2B by both reduced exocytosis and enhanced endocytosis of this subunit (Braithwaite et al. 2006 ; Nguyen et al. 2002 ; Paul et al. 2003 ; Snyder et al. 2005 ) . Acute applications of A b also decreased the amplitude of NMDAR-mediated currents in cultured neurons (Snyder et al. 2005 ) . "
    [Show abstract] [Hide abstract]
    ABSTRACT: Stroke is a very strong risk factor for dementia. Furthermore, ischemic stroke and Alzheimer's disease (AD) share a number of overlapping mechanisms of neuron loss and dysfunction, including those induced by the inappropriate activation of N-methyl-D-aspartate receptors (NMDARs). These receptors form a major subtype of excitatory glutamate receptor. They are nonselective cation channels with appreciable Ca(2+) permeability, and their overactivation leads to neurotoxicity in the cortex and hippocampus. NMDARs have therefore been therapeutic targets in both conditions, but they have failed in the treatment of stroke, and there is limited rationale for using them in treating AD. In this chapter, we discuss current understanding of subtypes of NMDARs and their potential roles in -ischemic stroke and AD. We also discuss the properties of several other nonselective cation channels, transient receptor potential melastatin 2 and 7 channels, and their implications in linking these conditions.
    Advances in Experimental Medicine and Biology 01/2013; 961:433-47. DOI:10.1007/978-1-4614-4756-6_37 · 2.01 Impact Factor
  • Source
    • "Provocative studies suggest that in the absence of tau, the postsynaptic targeting of nonreceptor tyrosine kinase Fyn is disrupted (Ittner et al., 2010). Fyn – a component of the postsynaptic density of excitatory synapses --phosphorylates NMDA receptor subunit GluN2B (also termed NR2B), thereby enhancing NMDA receptor surface expression and function, a process that is antagonized by the tyrosine phosphatase STEP (Braithwaite et al., 2006). Overexpression of Fyn exacerbates, whereas Fyn knockout ameliorates, the neuronal and cognitive deficits in APP transgenic mice, consistent with the idea that Fyn plays a role in AD, potentially in synergy with Abeta mediated toxicity (Chin et al., 2005). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Alzheimer's disease (AD) is a major cause of dementia in the elderly. Pathologically, AD is characterized by the accumulation of insoluble aggregates of Aβ-peptides that are proteolytic cleavage products of the amyloid-β precursor protein ("plaques") and by insoluble filaments composed of hyperphosphorylated tau protein ("tangles"). Familial forms of AD often display increased production of Aβ peptides and/or altered activity of presenilins, the catalytic subunits of γ-secretase that produce Aβ peptides. Although the pathogenesis of AD remains unclear, recent studies have highlighted two major themes that are likely important. First, oligomeric Aβ species have strong detrimental effects on synapse function and structure, particularly on the postsynaptic side. Second, decreased presenilin function impairs synaptic transmission and promotes neurodegeneration. The mechanisms underlying these processes are beginning to be elucidated, and, although their relevance to AD remains debated, understanding these processes will likely allow new therapeutic avenues to AD.
    Cold Spring Harbor perspectives in biology 04/2012; 4(5). DOI:10.1101/cshperspect.a005777 · 8.23 Impact Factor
Show more